PLIVA FDA Approval ANDA 088887

ANDA 088887

PLIVA

FDA Drug Application

Application #088887

Application Sponsors

ANDA 088887PLIVA

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL100MG0AMITRIPTYLINE HYDROCHLORIDEAMITRIPTYLINE HYDROCHLORIDE

FDA Submissions

ORIG1AP1984-09-26
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1985-06-17
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1985-06-17
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1988-03-22
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1991-07-29
BIOEQUIV; BioequivalenceSUPPL7AP1990-02-14
LABELING; LabelingSUPPL8AP1990-10-26
LABELING; LabelingSUPPL10AP1992-05-26
LABELING; LabelingSUPPL11AP1993-11-04
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1994-05-11
LABELING; LabelingSUPPL13AP1995-07-14
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1995-07-14
LABELING; LabelingSUPPL15AP1995-05-24
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2000-07-07
LABELING; LabelingSUPPL17AP2000-10-05
LABELING; LabelingSUPPL19AP2001-06-25

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL15Null0
SUPPL16Null0
SUPPL17Null0
SUPPL19Null0

CDER Filings

PLIVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 88887
            [companyName] => PLIVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMITRIPTYLINE HYDROCHLORIDE","activeIngredients":"AMITRIPTYLINE HYDROCHLORIDE","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"AMITRIPTYLINE HYDROCHLORIDE","submission":"AMITRIPTYLINE HYDROCHLORIDE","actionType":"100MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.